The Clicks growth strategy is moving the retailer beyond its pharmacy roots, with CEO Bertina Engelbrecht targeting GLP-1 medicines, specialist healthcare and medical consumables. Clicks has raised its pharmacy market share to 24.7% and operates 835 pharmacies and 225 clinics.
Engelbrecht sees GLP-1 medicines as the biggest short-term opportunity. These drugs treat diabetes and are increasingly prescribed for weight management. However, patients currently pay between R2,000 and R3,000 a month, which limits access.